SC Filed 2024-10-07 Event — SEC 0001193125-24-233941 →

Apeiron Investment Group Ltd. → BIONOMICS LIMITED/FI NEUP

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

6 transactions

6 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.00

15,334 shares short · -3.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-01-20	Wilson David Ian	director	Award	8,537	—	—
2026-01-20	Davies Peter Miles Winston	director	Award	8,537	—	—
2026-01-20	Fisher Alan	director	Award	17,073	—	—
2026-01-20	Ryan Jane	director	Award	8,537	—	—
2025-10-21	Lynx1 Capital Management LP	10%+ owner	Buy	639,110	$5.14	$3.28M
2025-08-27	Papapetropoulos Spyros	director, officer	Award	34,559	$8.27	$286K

Other 13D/G Filings on BIONOMICS LIMITED/FI

Filed	Form	Filer	Stake	Shares
2025-12-29	SCHEDULE	Lynx1 Capital Management LP	16.30%	875,328	view →
2025-01-28	SCHEDULE	Apeiron Investment Group Ltd.	4.50%	72,618	view →

Other Filings by Apeiron Investment Group Ltd.

Filed	Form	Issuer	Stake	Shares
2026-07-24	SCHEDULE 13D/A	Enhanced Group Inc.	26.60%	35,945,876	view →
2026-07-17	SCHEDULE 13D/A	AtaiBeckley Inc.	15.40%	55,770,948	view →
2026-06-16	SCHEDULE 13D/A	Enhanced Group Inc. ENHA	24.40%	29,904,746	view →
2026-05-14	SCHEDULE 13D	Enhanced Group Inc. ENHA	24.40%	29,904,746	view →
2025-01-28	SCHEDULE	Neuphoria Therapeutics Inc. NEUP	4.50%	72,618	view →
2023-05-23	SC	Sensei Biotherapeutics, Inc. SNSE	—	—	view →
2022-11-21	SC	Sensei Biotherapeutics, Inc. SNSE	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →